Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Effects of droxicam on in vivo prostaglandin synthesis and ex vivo platelet aggregation.

Esteve J, Martínez L, Roser R, Sagarra R.

Methods Find Exp Clin Pharmacol. 1987 Apr;9(4):209-13.

PMID:
3110512
2.

Pharmacological properties of droxicam, a new non-steroidal anti-inflammatory agent.

Farré AJ, Colombo M, Fort M, Gutiérrez B, Rodríguez L, Roser R.

Methods Find Exp Clin Pharmacol. 1986 Jul;8(7):407-22.

PMID:
3489870
3.

Pharmacological profile of droxicam.

Esteve J, Farré AJ, Roser R.

Gen Pharmacol. 1988;19(1):49-54. Review.

PMID:
3278945
4.

[The inhibitory effect of oxaprozin, a new non-steroidal anti-inflammatory drug, on platelet aggregation].

Goto J, Muramatsu M, Hosoda K, Otomo S, Aihara H.

Nihon Yakurigaku Zasshi. 1984 May;83(5):395-400. Japanese.

PMID:
6432657
5.

Trifenagrel: a chemically novel platelet aggregation inhibitor.

Abrahams SL, Hazen RJ, Batson AG, Phillips AP.

J Pharmacol Exp Ther. 1989 May;249(2):359-65.

PMID:
2542526
6.

Tepoxalin: a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile.

Argentieri DC, Ritchie DM, Ferro MP, Kirchner T, Wachter MP, Anderson DW, Rosenthale ME, Capetola RJ.

J Pharmacol Exp Ther. 1994 Dec;271(3):1399-408.

PMID:
7996452
9.
10.

Glucocorticoid effect on arachidonic acid metabolism in vivo.

Náray-Fejes-Tóth A, Rosenkranz B, Frölich JC, Fejes-Tóth G.

J Steroid Biochem. 1988;30(1-6):155-9.

PMID:
3386243
11.

The effect of arachidonic acid metabolism on intravascular platelet aggregation in rats.

Mallarkey G, Smith GM.

Thromb Res. 1984 Oct 15;36(2):91-102.

PMID:
6438829
12.

Synthesis and inhibitory effects of 2-pyridyl-2-thiobenzoxazole and 2-pyridyl-2-thiobenzimidazole derivatives on arachidonic acid metabolism.

Lagorce JF, Fatimi J, Lakhdar M, Chabernaud ML, Buxeraud J, Raby C.

Arzneimittelforschung. 1995 Nov;45(11):1207-10.

PMID:
8929241
13.

ZD9583, an orally effective thromboxane A2 synthase inhibitor and receptor antagonist with a sustained duration of action in rat and dog.

Brownlie RP, Brownrigg NJ, Butcher HM, Garcia R, Jessup R, Lee VJ, Tunstall S, Wayne MG.

J Pharm Pharmacol. 1997 Feb;49(2):187-94.

PMID:
9055193
14.
15.

Relative effects of aspirin on platelet aggregation and prostaglandin-mediated coronary vasodilatation in the dog.

Capurro NL, Lipson LC, Bonow RO, Goldstein RE, Shulman NR, Epstein SE.

Circulation. 1980 Dec;62(6):1221-7.

PMID:
7438358
16.

Piroxicam, a structurally novel anti-inflammatory compound. Mode of prostaglandin synthesis inhibition.

Carty TJ, Stevens JS, Lombardino JG, Parry MJ, Randall MJ.

Prostaglandins. 1980 May;19(5):671-82.

PMID:
6775350
17.
18.
20.

[Action of nonsteroidal anti-inflammatory agents on fibrinolysis and platelet aggregation].

Lakin KM, Schipilowa SJ, Nowikowa NW, Rukasenkow JE, Pomojnezkij WD, Grenadjorow SJ.

Folia Haematol Int Mag Klin Morphol Blutforsch. 1986;113(1-2):230-5. German.

PMID:
2427406

Supplemental Content

Support Center